Science Explorer Back to mapMap
Discussion
Company · Wilmington · United States

Pharmaceutical Product Development (United States)

In research, Pharmaceutical Product Development (United States) stands highest in Health Sciences (#4,229 of 16,688 worldwide), Medicine (#3,753 of 14,558 worldwide) and Life Sciences (#3,314 of 11,023 worldwide), over all time.

ppdi.comROR OpenAlex
World rank, all time
#8,371
of 34,923
Rank in United States
#1,741
of 7,310
Research works
498
▼ 39% vs 2018-21
Citations
16k
32.5 per fractional work
Top-10% rate
13.2%
all institutions 10.0%
vs its own fields
1.11×
1.00× is exactly expected
Open access
32%
world 40%
International
24%
world 18%
Pharmaceutical Product Development (United States)

What is Pharmaceutical Product Development (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #4,229 of 16,688 12.7%195
MedicineField #3,753 of 14,558 12.7%177
Life SciencesDomain #3,314 of 11,023 13.1%150

Each strip is that field's whole ranked pool, with the notch where Pharmaceutical Product Development (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Pharmaceutical Product Development (United States) work in?

In 2022-now, 36% of research at Pharmaceutical Product Development (United States) is in Health Sciences, 27% in Life Sciences. Its largest fields are Medicine (32%), Biochemistry, Genetics and Molecular Biology (15%), Engineering (11%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 18 fractional works · 36.0% of its workMedicine: 16 fractional works · 32.0% of its workPsychiatry and Mental health: 2 fractional works · 3.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 2.4% of its workInfectious Diseases: 1 fractional works · 2.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.0% of its workOncology: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.4% of its workRheumatology: 1 fractional works · 1.3% of its workNephrology: 1 fractional works · 1.2% of its workSurgery: 1 fractional works · 1.2% of its workPhysiology: 1 fractional works · 1.1% of its workDermatology: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workTransplantation: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.2% of its workGastroenterology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.9% of its workHealth Professions: 2 fractional works · 3.4% of its workGeneral Health Professions: 1 fractional works · 2.1% of its workOccupational Therapy: 0 fractional works · 0.9% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 14 fractional works · 27.5% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 15.2% of its workMolecular Biology: 5 fractional works · 10.2% of its workGenetics: 2 fractional works · 3.7% of its workBiochemistry: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 5.1% of its workImmunology: 2 fractional works · 4.7% of its workVirology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.6% of its workPharmaceutical Science: 1 fractional works · 2.6% of its workPharmacology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 2.0% of its workCognitive Neuroscience: 1 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.6% of its workFood Science: 1 fractional works · 1.3% of its workPlant Science: 0 fractional works · 0.3% of its workPhysical Sciences: 12 fractional works · 23.0% of its workEngineering: 6 fractional works · 11.0% of its workBiomedical Engineering: 2 fractional works · 4.0% of its workElectrical and Electronic Engineering: 2 fractional works · 3.2% of its workMechanical Engineering: 1 fractional works · 1.4% of its workAutomotive Engineering: 0 fractional works · 0.7% of its workControl and Systems Engineering: 0 fractional works · 0.7% of its workCivil and Structural Engineering: 0 fractional works · 0.4% of its workComputational Mechanics: 0 fractional works · 0.3% of its workMechanics of Materials: 0 fractional works · 0.3% of its workComputer Science: 3 fractional works · 5.4% of its workArtificial Intelligence: 2 fractional works · 3.5% of its workInformation Systems: 0 fractional works · 0.9% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workComputer Science Applications: 0 fractional works · 0.5% of its workMaterials Science: 1 fractional works · 2.8% of its workBiomaterials: 1 fractional works · 1.3% of its workMaterials Chemistry: 1 fractional works · 1.2% of its workPolymers and Plastics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 1 fractional works · 1.7% of its workStatistics and Probability: 1 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workPollution: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.5% of its workGeophysics: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workRadiation: 0 fractional works · 0.5% of its workEnergy: 0 fractional works · 0.2% of its workGeneral Energy: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.1% of its workSocial Sciences: 7 fractional works · 13.5% of its workPsychology: 3 fractional works · 5.3% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.8% of its workClinical Psychology: 1 fractional works · 2.1% of its workSocial Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 4.0% of its workPolitical Science and International Relations: 1 fractional works · 2.0% of its workSociology and Political Science: 0 fractional works · 0.7% of its workLaw: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workArts and Humanities: 1 fractional works · 2.2% of its workArcheology: 1 fractional works · 1.3% of its workVisual Arts and Performing Arts: 0 fractional works · 0.4% of its workHistory: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.6% of its workEconomics and Econometrics: 1 fractional works · 1.3% of its workFinance: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.5% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKPharmaceuticalProduct…50fractional works, 2022-now
Life Sciences27%Physical Sciences23%Health Sciences36%Social Sciences14%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 25 fields, with their numbers
    1. Medicine1632.0%
    2. Health Professions23.4%
    3. Nursing00.3%
    4. Dentistry00.1%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology815.2%
    2. Immunology and Microbiology35.1%
    3. Pharmacology, Toxicology and Pharmaceutics23.6%
    4. Neuroscience12.0%
    5. Agricultural and Biological Sciences11.6%
    1. Engineering611.0%
    2. Computer Science35.4%
    3. Materials Science12.8%
    4. Mathematics11.7%
    5. Environmental Science00.6%
    6. Earth and Planetary Sciences00.5%
    7. Physics and Astronomy00.5%
    8. Energy00.2%
    9. Chemical Engineering00.1%
    10. Chemistry00.1%
    1. Psychology35.3%
    2. Social Sciences24.0%
    3. Arts and Humanities12.2%
    4. Economics, Econometrics and Finance11.6%
    5. Decision Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.35× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.86× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 5.09× its world share, 3 worksImmunology and Micro…Neuroscience: 1.20× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.07× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.38× its world share, 0 worksChemical EngineeringChemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.70× its world share, 3 worksComputer ScienceEarth and Planetary Sciences: 0.32× its world share, 0 worksEarth and Planetary …Energy: 0.24× its world share, 0 worksEnergyEngineering: 0.73× its world share, 6 worksEngineeringEnvironmental Science: 0.11× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.81× its world share, 1 worksMaterials ScienceMathematics: 1.45× its world share, 1 worksMathematicsPhysics and Astronomy: 0.22× its world share, 0 worksPhysics and AstronomyDentistry: 0.27× its world share, 0 worksDentistryHealth Professions: 1.28× its world share, 2 worksHealth ProfessionsMedicine: 1.67× its world share, 16 worksMedicineNursing: 0.68× its world share, 0 worksNursingVeterinary: 0.56× its world share, 0 worksVeterinaryArts and Humanities: 0.76× its world share, 1 worksArts and HumanitiesDecision Sciences: 0.51× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.73× its world share, 1 worksEconomics, Econometr…Psychology: 1.75× its world share, 3 worksPsychologySocial Sciences: 0.31× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.1×. Every wedge is a field page.

All 25 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics10.07×2 works
  2. Immunology and Microbiology5.09×3 works
  3. Biochemistry, Genetics and Molecular Biology2.86×8 works
  4. Psychology1.75×3 works
  5. Medicine1.67×16 works
  6. Mathematics1.45×1 works
  7. Health Professions1.28×2 works
  8. Neuroscience1.20×1 works
  9. Materials Science0.81×1 works
  10. Arts and Humanities0.76×1 works
  11. Engineering0.73×6 works
  12. Economics, Econometrics and Finance0.73×1 works
  13. Computer Science0.70×3 works
  14. Nursing0.68×0 works
  15. Veterinary0.56×0 works
  16. Decision Sciences0.51×0 works
  17. Chemical Engineering0.38×0 works
  18. Agricultural and Biological Sciences0.35×1 works
  19. Earth and Planetary Sciences0.32×0 works
  20. Social Sciences0.31×2 works
  21. Dentistry0.27×0 works
  22. Energy0.24×0 works
  23. Physics and Astronomy0.22×0 works
  24. Environmental Science0.11×0 works
  25. Chemistry0.08×0 works

Who are the top researchers at Pharmaceutical Product Development (United States)?

Ranked on the quality score, Steven J. Shire, Dirk J. Reitsma and Junyan A. Ji lead among researchers whose main affiliation is Pharmaceutical Product Development (United States).

  1. 1 Steven J. Shire United States · #137,660 worldwide 9k citations · 120 works
  2. 2 Dirk J. Reitsma United States · #365,311 worldwide 8.5k citations · 59 works
  3. 3 Junyan A. Ji United States · #400,360 worldwide 1.8k citations · 27 works
  4. 4 James D. Andya United States · #627,747 worldwide 2.1k citations · 17 works
  5. 5 Thomas W. Patapoff United States · #722,765 worldwide 3.7k citations · 68 works
  6. 6 Susan D. Wilson United States · #859,931 worldwide 2.2k citations · 62 works
  7. 7 Jai Balkissoon United States · #985,809 worldwide 1.8k citations · 27 works
  8. 8 Chris Beaver United States · #1,395,975 worldwide 768 citations · 26 works
  9. 9 Nicola C. Hughes United States · #1,549,658 worldwide 2.3k citations · 51 works
  10. 10 Y. John Wang United States · #1,910,605 worldwide 802 citations · 16 works
All ranked researchers at Pharmaceutical Product Development (United States)

What are the most cited papers from Pharmaceutical Product Development (United States)?

The most cited paper from Pharmaceutical Product Development (United States) is "Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease" (Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al., 2012), with 1,628 citations. Next come "Delamanid for Multidrug-Resistant Pulmonary Tuberculosis" (748) and "Heat transfer properties of nanoparticle-in-fluid dispersions (nanofluids) in laminar flow" (729).

Most cited papers
#PaperReleasedCitations
1 Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine Open access 3 Nov 2012 1,628
2 Delamanid for Multidrug-Resistant Pulmonary Tuberculosis Maria Tarcela Gler et al. · New England Journal of Medicine Open access 7 Jun 2012 748
3 Heat transfer properties of nanoparticle-in-fluid dispersions (nanofluids) in laminar flow Ying Yang, Z. George Zhang, Eric A. Grulke et al. · International Journal of Heat and Mass Transfer 12 Dec 2004 729
4 The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program Carole W. Cranor, Barry A. Bunting, Dale B. Christensen · Journal of the American Pharmaceutical Association (1996) Mar 2003 728
5 Challenges in the Development of High Protein Concentration Formulations Steven J. Shire, Zahra Shahrokh, Jun Liu Book chapter 10 Oct 2009 658
All 58 most cited papers, with filters and sorting

Which keywords describe research at Pharmaceutical Product Development (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Immunogenicity, Recombinant Proteins, Stability, Chromatography and Protein Aggregation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Monoclonal Antibodies4▲ 99×3 topics
  2. Epidemiology4▲ 1.98×27 topics
  3. Therapeutic Antibodies4▲ 105×2 topics
  4. Biopharmaceuticals3▲ 121×3 topics
  5. Immunogenicity3▲ 145×3 topics
  6. Nanoparticles3▲ 4.1×7 topics
  7. Treatment3▲ 4.3×10 topics
  8. Recombinant Proteins2▲ 150×2 topics
  9. Stability2▲ 21×2 topics
  10. Chromatography2▲ 299×1 topic
  11. Protein Aggregation2▲ 84×1 topic
  12. Genetics2▲ 6.0×8 topics
  13. Glycosylation2▲ 37×3 topics
  14. Meta-Analysis2▲ 7.1×4 topics
  15. Inflammation2▲ 1.90×15 topics
  16. Clinical Trials2▲ 5.6×8 topics
  17. Diagnosis2▲ 4.0×10 topics
  18. Metabolic Syndrome2▲ 3.6×5 topics
  19. Antibody Engineering1▲ 52×1 topic
  20. Fc Receptors1▲ 52×1 topic
  21. Neurobiology1▲ 11×3 topics
  22. Quality of Life1▲ 1.98×10 topics
  23. Cancer1▲ 2.0×5 topics
  24. Immune Response1▲ 4.4×8 topics
  25. Prevalence1▲ 6.3×2 topics
  26. ADHD1▲ 64×1 topic
  27. Attention-Deficit/Hyperactivity Disorder1▲ 64×1 topic
  28. Brain Imaging1▲ 31×2 topics
  29. Deep Learning1▼ 0.67×5 topics
  30. Drug Delivery1▲ 4.2×3 topics
  31. Machine Learning1▼ 0.69×5 topics
  32. Ciliopathies1▲ 133×1 topic
  33. Primary Cilium1▲ 133×1 topic
  34. Vaccine1▲ 5.5×6 topics
  35. Biomedical Applications1▲ 1.71×6 topics
  36. Clinical Outcomes1▲ 9.5×3 topics
  37. Global Governance1▲ 8.6×3 topics
  38. Security Council1▲ 40×2 topics

Which research topics does Pharmaceutical Product Development (United States) publish most on?

By volume in 2022-now: Protein purification and stability, Monoclonal and Polyclonal Antibodies Research, Attention Deficit Hyperactivity Disorder and Genetic and Kidney Cyst Diseases.

Protein purification and…2Protein purification and stability: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksAttention Deficit Hypera…1Attention Deficit Hyperactivity Disorder: 1 fractional worksGenetic and Kidney Cyst …1Genetic and Kidney Cyst Diseases: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksDrug Solubulity and Delivery Systems: 1 fractional worksSleep and related disord…1Sleep and related disorders: 1 fractional worksSleep and Work-Related Fatigue: 1 fractional worksPsychiatric care and mental health services: 1 fractional worksBiological Research and Disease Studies: 1 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingPsychiatry and Mental healthGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein purification and stability Molecular Biology 2 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 1 works
  4. 4 Genetic and Kidney Cyst Diseases Genetics 1 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 1 works
  6. 6 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
  7. 7 Sleep and related disorders Experimental and Cognitive Psychology 1 works
  8. 8 Sleep and Work-Related Fatigue Experimental and Cognitive Psychology 1 works
  9. 9 Psychiatric care and mental health services Clinical Psychology 1 works
  10. 10 Biological Research and Disease Studies Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.9%not open68.1%

World: 40% of research is openly available.

with international co-authors24.3%domestic only75.7%

World: 18% is written across borders.

How has Pharmaceutical Product Development (United States)'s research output changed?

Output in 2022-2025 was 39% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharmaceutical Product Development (United States) as a percentage of every work published that year, 0.00018% in 2024.

still counting0.00050%0.0010%0.0015%Pharmaceutical Product Development (United States)0.00019% in 202519801990200020102020

Fractional works of Pharmaceutical Product Development (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%Pharmaceutical Product Development (United States)18.6% in 2017all institutions10.0% in 20172010

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 24.2% in 2009.

Other research institutions in Wilmington

All research institutions in Wilmington

Share Pharmaceutical Product Development (United States)'s ranking

Pharmaceutical Product Development (United States) on Science Explorer

A card with Pharmaceutical Product Development (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmaceutical Product Development (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.